Wharton's Jelly mesenchymal stem cells (expanded)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Wharton's Jelly mesenchymal stem cells (expanded), covering 2020-02-17 to 2020-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Intrathecal Administration of Expanded Wharton's Jelly Mesenchymal Stem Cells in Chronic Traumatic Spinal Cord Injury [Phase 1, Phase 2]